Companies Dominating the Heparin Landscape
- Aspen Holdings
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Opocrin S.p.A.
- LEO Pharma Inc.
- Baxter
- Dr. Reddy’s Laboratories Ltd.
- Pfizer Inc.
- B. Braun Medical Inc.
- Bioiberica S.A.U.
- Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
- Fresenius Kabi Canada
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
2025 Heparin Market is assessed at USD 11.33 billion.
The global heparin market size was worth over USD 10.94 billion in 2024 and is expected to see a CAGR exceeding 4.4%, reaching over USD 19.15 billion by 2037.
North America is set to capture the leading share, led by rising chronic kidney disease cases and higher healthcare expenditure.
The major players in the market include Aspen Holdings, Opocrin S.p.A., LEO Pharma Inc., Baxter, Dr. Reddy’s Laboratories Ltd., Pfizer Inc., B. Braun Medical Inc., Bioiberica S.A.U., Hebei Changshan Biochemical Pharmaceutical Co., Ltd., Fresenius Kabi Canada.
